Association between Colchicine and Risk of Diabetes among the Veterans Affairs Population with Gout

Clinical Therapeutics

Volumn 37, Issue 6, 2015, Pages 1206-1215

  Wang, Liya ^a   Sawhney, Monika ^b   Zhao, Yingnan ^c   Carpio, Gandahari Rosa ^d   Fonseca, Vivian ^a,d   Shi, Lizheng ^a,d  

^a TULANE UNIVERSITY   (United States)

^b MARSHALL UNIVERSITY   (United States)

^c XAVIER UNIVERSITY OF LOUISIANA   (United States)

^d TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

colchicine; diabetes; gout; veterans

Indexed keywords

ALLOPURINOL; COLCHICINE; PREDNISONE; PROBENECID; TRIAMCINOLONE; ANTIGOUT AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GOUT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROPENSITY SCORE; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT DURATION; VETERAN; AGED; CASE CONTROL STUDY; PROPORTIONAL HAZARDS MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AGED; CASE-CONTROL STUDIES; COLCHICINE; DIABETES MELLITUS; FEMALE; GOUT; GOUT SUPPRESSANTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; UNITED STATES; VETERANS;

EID: 84931004179     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2015.03.010     Document Type: Article

References (28)

1. A.J. Luk, and P.A. Simkin Epidemiology of hyperuricemia and gout Am J Managed Care 11 2005 S435 S442 quiz S465-S438
2. Y. Zhu, B.J. Pandya, and H.K. Choi Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008 Arthritis Rheum 63 2011 3136 3141
3. L. Sachs, K.L. Batra, and B. Zimmermann Medical implications of hyperuricemia Med Health R I 92 2009 353 355
4. N.L. Edwards The role of hyperuricemia in vascular disorders Curr Opin Rheumatol 21 2009 132 137
5. D. Axelrod, and S. Preston Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout Arthritis Rheum 31 1988 803 805
6. M.H. Pillinger, D.S. Goldfarb, and R.T. Keenan Gout and its comorbidities Bull NYU Hosp Jt Dis 68 2010 199 203
7. P. Primatesta, E. Plana, and D. Rothenbacher Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population BMC Musculoskel Disord 12 2011 103
8. H.K. Choi, M.A. De Vera, and E. Krishnan Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile Rheumatology (Oxford) 47 2008 1567 1570
9. W. Zhang, M. Doherty, and T. Bardin EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) Ann Rheum Dis 65 2006 1312 1324
10. N. Schlesinger, R. Schumacher, M. Catton, and L. Maxwell Colchicine for acute gout Cochrane Database Syst Rev 2006 CD006190
11. R.A. Terkeltaub Gout N Engl J Med 349 2003 1647 1655
12. Y. Molad Update on colchicine and its mechanism of action Curr Rheumatol Rep 4 2002 252 256
13. U.N. Das Colchicine in diabetes mellitus J Assoc Physicians India 41 1993 213
14. C. Kastner, J. Armitage, and A. Kimble The Charlson comorbidity score: a superior comorbidity assessment tool for the prostate cancer multidisciplinary meeting Prostate Cancer Prostatic Dis 9 2006 270 274
15. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
16. G. Heinze, and P. Juni An overview of the objectives of and the approaches to propensity score analyses Eur Heart J 32 2011 1704 1708
17. M. Caliendo, and S. Kopeinig Some practical guidance for the implementation of propensity score matching J Econ Surv 22 2008 31 72
18. M.C. Wasko, H.B. Hubert, and V.B. Lingala Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis JAMA 298 2007 187 193
19. C.A. Bellera, G. MacGrogan, and M. Debled Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer BMC Med Res Method 10 2010 20
20. D.B. Crittenden, R.A. Lehmann, and L. Schneck Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout J Rheumatol 39 2012 1458 1464
21. A.P. Kengne, G.D. Batty, and M. Hamer Association of C-reactive protein with cardiovascular disease mortality according to diabetes status: pooled analyses of 25,979 participants from four U.K. prospective cohort studies Diabetes Care 35 2012 396 403
22. D.M. Maahs, and J.K. Snell-Bergeon Current knowledge and future directions on cardiovascular disease in diabetes Diabetes Technol Ther 14 suppl 1 2012 S75 S76
23. R.W. Nesto, and R.T. Phillips Asymptomatic myocardial ischemia in diabetic patients Am J Med 80 1986 40 47
24. M.C. Lansang, and L.K. Hustak Glucocorticoid-induced diabetes and adrenal suppression: how to detect and manage them Cleve Clin J Med 78 2011 748 756
25. D. Blackburn, J. Hux, and M. Mamdani Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly J Gen Intern Med 17 2002 717 720
26. J.L. Hwang, and W. RE Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment Diabetes/Metab Res Rev 30 2014 96 102
27. L.-Y. Chen, W.-H. Zhu, and Z.-W. Chen Relationship between hyperuricemia and metabolic syndrome J Zhejiang Univ Sci B 8 2007 593 598
28. V. Bhole, J.W. Choi, and S.W. Kim Serum uric acid levels and the risk of type 2 diabetes: a prospective study Am J Med 123 2010 957 961